Radiation protection recommendations for I-131 thyrotoxicosis, thyroid cancer and phaeochromocytoma patients

Australasian Physical and Engineering Sciences in Medicine

Volumn 27, Issue 3, 2004, Pages 118-128

  Woodings, Simon ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Dialysis; Iodine 131; Phaeochromocytoma; Radiation protection; Thyroid carcinoma; Thyrotoxicosis

Indexed keywords

CHARACTERIZATION; DATA REDUCTION; DIALYSIS; PATIENT TREATMENT; TUMORS;

RECOMMENDATIONS; THYROID CANCER PATIENTS; THYROTOXICOSIS;

RADIATION PROTECTION;

IODINE 131;

ARTICLE; CANCER RADIOTHERAPY; CAREGIVER; CHILD CARE; CONTROLLED STUDY; DIALYSIS; DOSIMETRY; DRUG CLEARANCE; DRUG HALF LIFE; FAMILY; HUMAN; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MEDICAL LITERATURE; PATIENT CARE; PATIENT TRANSPORT; PHEOCHROMOCYTOMA; RADIATION DOSE; RADIATION HAZARD; RADIATION PROTECTION; RADIOACTIVITY; SOCIAL BEHAVIOR; THERMOLUMINESCENCE DOSIMETRY; THYROID CANCER; THYROTOXICOSIS; WORK ENVIRONMENT;

EID: 8744226972     PISSN: 01589938     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03178671     Document Type: Article

References (22)

1. ARPANSA, Discharge of patients undergoing treatment with radioactive substances. Radiation Protection Series No. 4, 2002.
2. Buchan, R. C. T. and Brindle, J. M. Radioiodine therapy to out-patients - the contamination hazard. Br J Radiol, 43: p. 479-482, 1970.
3. O'Doherty, M. J., et al., Radiation dose rates from adult patients receiving 131I therapy for thyrotoxicosis. Nucl Med Commun, 14: p. 160-168, 1993.
4. Reiners, C. and Lassmann, M. Radioiodine (131I) treatment of hyperthyroidism: radiation protection and quality assurance. Eur J Nucl Med, 26: p. 683-685, 1999.
5. Handbook of Health Physics and Radiological Health. 3rd ed, ed. B. Shleien, L.A. Slaback Jr, and B.K. Birky. Baltimore: Williams and Wilkins, 1998.
6. Barrington, S. F., et al., Radioactive exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism. Eur J Nucl Med, 26: p. 686-692, 1999.
7. Monsieurs, M., et al., Real-life radiation burden to relatives of patients treated with iodine-131: a study in eight centres in Flanders (Belgium). Eur J Nucl Med, 25: p. 1368-1376, 1998.
8. Mathieu, I., et al., Doses in family members after 131I treatment. The Lancet, 350: p. 1074-1075, 1997.
9. Culver, C. M. and Dworkin, H. J. Radiation safety considerations for post-iodine-131 thyroid cancer therapy. J Nucl Med, 33: p. 1402-1405, 1992.
10. Barrington, S. F., et al., Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid. Eur J Nucl Med, 23: p. 123-130, 1996.
11. Nath, R., et al., Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM radiation therapy committee task group no. 43. Med Phys, 22: p. 209-234, 1995.
12. Mountford, P. J., Estimation of close contact doses to young infants from surface dose rates on radioactive adults. Nucl Med Commun, 8: p. 857-863, 1987.
13. Cormack, J. and Shearer, J. Calculation of radiation exposures from patients to whom radioactive materials have been administered. Phys Med Biol, 43: p. 501-516, 1998.
14. Hilditch, T. E., et al., Radiological protection guidance for radioactive patients - new data for therapeutic 131I. Nucl Med Commun, 12: p. 485-495, 1991.
15. European Commission, Radiation protection 97. Office for Official Publications of the European Communities: Luxembourg. p. 1-34, 1998.
16. ICRP, Publication 60: 1990 Recommendations of the International Commission on Radiological Protection, ed. H. Smith., Pergamon Press, 1990:
17. Wasserman, H. and Groenewald, W. Air kerma rate constants for radionuclides. Eur J Nucl Med, 14: p. 569-571, 1988.
18. ICRU, ICRU Report 47 Measurement of Dose Equivalents from External Photon and Electron Radiations, International Commission on Radiation Units and Measurements: Bethesda, USA, 1992.
19. Burrage, J. W., The development of a system to measure retained bodily activity after iodine-131 therapy. Royal Perth Hospital: Perth, Australia, 1997.
20. Morrish, D. W., et al., 131I treatment of thyroid papillary carcinoma in a patient with renal failure. Cancer, 66: p. 2509-2513, 1990.
21. Wasserman, H. J. and Klopper, J. F. Analysis of radiation doses received by the public from 131I treatment of thyrotoxic outpatients. Nuc Med Commun, 14: p. 756-760, 1993.
22. NCRP, Report No. 105. Bethesda USA, 1989.